A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection
Clinical trial NCT01692470 · WITHDRAWN
Trial details
- NCT number
- NCT01692470
- Sponsor
- Janssen Pharmaceutica
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.